Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2026-06-26 @ 5:49 AM
Study NCT ID:
NCT05654194
Status:
UNKNOWN
Last Update Posted:
2022-12-16
First Post:
2022-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SOOCHOW-HY-2022-11-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None